Decreased Polymorphonuclear Leukocyte Deformability in NIDDM

OBJECTIVE To determine the rheological properties of polymorphonuclear leukocytes (PMN) from non-insulin-dependent diabetes mellitus (NIDDM) patients. RESEARCH DESIGN AND METHODS The deformability of PMN from 33 NIDDM subjects, 13 with impaired glucose tolerance (IGT), and 22 with normal glucose tolerance (NGT) was studied. A Cell Transit Analyzer that measures the transit time of PMN through 8-(xm pores was used. Studies were performed under three different conditions: J) basal state; 2) after incubation with cytochalasin B (20 μM) to dissociate f-actin from the cytoskeleton; and 3) following activation with N-formyl-methionyl-leucyl-phenylalanine (fMLP, 1 nM). RESULTS PMN from diabetic patients were more rigid (i.e., had longer transit time) than those from subjects with NGT or IGT under basal conditions and after cytochalasin B, but not after stimulation with fMLP. The deformability of PMN from subjects with IGT was similar to those of the NGT group. In the pooled data, basal transit time correlated with age; systolic and diastolic blood pressure; HbA1c; and serum creatinine, cholesterol, and triglyceride concentrations (r = 0.29, 0.34, 0.37, 0.48, 0.25, 0.36, 0.29, respectively, P < 0.05 for each). Hypertensive diabetic patients had less deformable PMN than normotensive ones. No relation was found between PMN deformability and the duration of diabetes, type of treatment, or the presence of retinopathy. CONCLUSIONS These data indicate increased rigidity of PMN in NIDDM that may contribute to development of microcirculatory disturbances and microangiopathy.

[1]  G. Lowe,et al.  Free Radical Activity and Hemostatic Factors in NIDDM Patients With and Without Microalbuminuria , 1992, Diabetes.

[2]  T C Fisher,et al.  Pulse shape analysis of RBC micropore flow via new software for the cell transit analyser (CTA). , 1992, Biorheology.

[3]  G. Schmid-Schönbein,et al.  Elevation of organ resistance due to leukocyte perfusion. , 1992, The American journal of physiology.

[4]  P. Bennett,et al.  Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. , 1991, Archives of internal medicine.

[5]  D. Giugliano,et al.  Metabolic Control May Influence the Increased Superoxide Generation in Diabetic Serum , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[6]  W. Koenig,et al.  Effects of felodipine ER and hydrochlorothiazide on blood rheology in essential hypertension—a randomized, double‐blind, crossover study , 1991, Journal of internal medicine.

[7]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[8]  M. Gilcrease,et al.  Neutrophil adhesion to endothelium following hyperosmolar insult. , 1991, Diabetes research.

[9]  F. Delano,et al.  Leukocyte Counts and Activation in Spontaneously Hypertensive and Normotensive Rats , 1991, Hypertension.

[10]  M. Leschke,et al.  Blood rheology as a contributing factor in reduced coronary reserve in systemic hypertension. , 1990, The American journal of cardiology.

[11]  L. Lindbom,et al.  Leukocyte‐Cell Adhesion: A Molecular Process Fundamental in Leukocyte Physiology , 1990, Immunological reviews.

[12]  H. Egawa,et al.  Decreased Fluidity of Polymorphonuclear Leukocyte Membrane in Streptozocin-Induced Diabetic Rats , 1990, Diabetes.

[13]  I. Greer,et al.  Increased Neutrophil Activation in Diabetic Pregnancy and in Nonpregnant Diabetic Women , 1989, Obstetrics and gynecology.

[14]  B. Clarke,et al.  Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus. , 1989, Diabetes research.

[15]  S. Weiss Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[16]  F. Zannad,et al.  Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy. , 1988, Journal of hypertension.

[17]  R. Wersto,et al.  The effects of sulfhydryl inhibitors and cytochalasin on the cytoplasmic and cytoskeletal actin of human neutrophils , 1987, Journal of cellular physiology.

[18]  E Ernst,et al.  Altered Red and White Blood Cell Rheology in Type II Diabetes , 1986, Diabetes.

[19]  H. J. Barnes Blood rheology in diabetes mellitus. , 1986, Acta medica portuguesa.

[20]  V. Dzau,et al.  Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. , 1984, Biochemistry.

[21]  H. Parving,et al.  EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY , 1983, The Lancet.

[22]  H. Meiselman,et al.  Membrane mechanical properties of erythrocytes from patients with diabetic retinopathy , 1982 .

[23]  S Chien,et al.  Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. , 1981, The American journal of medicine.

[24]  C. Peterson,et al.  Hematologic alterations in diabetes mellitus. , 1981, The American journal of medicine.

[25]  P. Bennett,et al.  Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. , 1980, The New England journal of medicine.

[26]  D. McMillan,et al.  Reduced Erythrocyte Deformability in Diabetes , 1978, Diabetes.

[27]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[28]  D. McMillan Disturbance of serum viscosity in diabetes mellitus. , 1974, The Journal of clinical investigation.

[29]  G Bucolo,et al.  Quantitative determination of serum triglycerides by the use of enzymes. , 1973, Clinical chemistry.

[30]  J. Ditzel,et al.  Blood-viscosity in diabetic patients. , 1966, Lancet.

[31]  H. Meiselman,et al.  Kinetics of granulocyte deformability following exposure to chemotactic stimuli. , 1992, Blood cells.

[32]  W. Kirchain,et al.  Effects of glycemic control on red cell deformability determined by using the cell transit time analyzer. , 1991, The Journal of laboratory and clinical medicine.

[33]  H. Meiselman,et al.  A new micropore filtration approach to the analysis of white cell rheology. , 1990, Biorheology.

[34]  A. M. Lefer,et al.  Leukocyte-dependent and leukocyte-independent mechanisms of impairment of endothelium-mediated vasodilation. , 1990, Blood vessels.

[35]  J. Smolen,et al.  Early biochemical events in leukocyte activation. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[36]  H. Meiselman,et al.  Determination of erythrocyte transit times through micropores. II-- Influence of experimental and physicochemical factors. , 1988, Biorheology.

[37]  H. Schmid-schönbein,et al.  Red-cell aggregation and red-cell deformability in diabetes. , 1976, Diabetes.

[38]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .